Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria | American Society of Nephrology
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
Summary scheme. FG-3019 attenuated proliferation and induced apoptosis... | Download Scientific Diagram
Frontiers | Vascular Endothelial Cell-Specific Connective Tissue Growth Factor (CTGF) Is Necessary for Development of Chronic Hypoxia-Induced Pulmonary Hypertension
Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer - ESMO Open
FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis | European Respiratory Society
Dose-dependence of target-mediated elimination of FG-3019. The percent... | Download Scientific Diagram
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
The FG-3019 binding epitope overlaps with the VWC domain of connective... | Download Scientific Diagram
FibroGen: Update To Thesis - IPF Data In Focus (NASDAQ:FGEN) | Seeking Alpha
EX-99.1
Temple Researchers Reverse Muscle Fibrosis from Overuse Injury in Animals, Raising Hope for Clinical Trials in Humans | Temple Health
DMD: start at I-Motion of trials with pamrevlumab in ambulatory and non-ambulatory patients - Institut de Myologie
IPF Disease Management Strategies With an Update on Clinical Trials - ppt download
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer | PNAS
EX-99.1
Pamrevlumab Study Shows Positive Results for IPF, FibroGen Announces
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase
Pamrevlumab - Parent Project Muscular Dystrophy
IJMS | Free Full-Text | Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development | HTML
EX-99.1
